$INM Cashflow Statement | Understand Stock

$INM

$1.59 +$0.00 (0.0%) Close

$INM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Operating Activities
Net loss
Items not requiring cash:
Amortization and depreciation
Share-based compensation
Amortization of right-of-use assets
Loss on disposal of assets
Impairment of intangible assets and goodwill
Inventory write-down
Credit losses
Warrant modification expense
Loss on disposal of fixed assets
Impairment of fixed assets
Impairment of intangible assets
Interest income received on short-term investments
Unrealized foreign exchange loss

Changes in operating assets and liabilities:
Inventories
Prepaids and other currents assets
Other non-current assets
Accounts receivable
Accounts payable and accrued liabilities
Deferred rent
Lease obligations
Operating cash flow used by discontinued operations
Total cash used in operating activities
Investing Activities
Cash acquired from acquisition of BayMedica
Payment of acquisition consideration payable
Payment of acquisition consideration
Payment of deposit on equipment
Purchase of property and equipment
Sale of short-term investments
Sale of short-term investments

Loan receivable
Purchase of short-term investments
Total cash used in investing activities
Financing Activities
Shares issued for cash
Share issuance costs
Repayment of debt
Proceeds from the sale of pre-funded warrants

Total cash provided by financing activities
Increase (decrease) in cash during the year
Cash and cash equivalents beginning of the period
Increase (decrease) in cash and cash equivalents during the period
Cash and cash equivalents beginning of the year
Cash and cash equivalents end of the year
SUPPLEMENTARY CASH FLOW INFORMATION:
Cash paid during the period for:
Income taxes
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Amortization of right-of-use assets
Deemed dividends
Fixed asset reclassified to held for sale equipment
Recognition of Right-of-use asset and corresponding operating lease
Preferred investment options to its placement agent
Warrants to its placement agent
Fair value of warrant modification recorded as equity issuance costs
Fair value of warrant modification recorded as equity issuance

Comments